SEARCH

SEARCH BY CITATION

References

  • Bales K. R., Verina T., Cummins D. J. et al. (1999) Apolipoprotein E is essential for amyloid deposition in the APP (V717F) transgenic mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 96, 15 23315 238.
  • Bettini E., Magnani E. and Terstappen G. C. (2002) Lithium induces gene expression through lymphoid enhancer-binding factor/T-cell factor responsive element in rat PC12 cells. Neurosci. Lett. 317, 5052.
  • Bu G., Sun Y., Schwartz A. L. and Holtzman D. M. (1998) Nerve growth factor induces rapid increases in functional cell surface low density lipoprotein receptor-related protein. J. Biol. Chem. 273, 13 35913 365.
  • Calderone A., Jover T., Noh K. M., Tanaka H., Yokota H., Lin Y., Grooms S. Y., Regis R., Bennett M. V. and Zukin R. S. (2003) Ischemic insults derepress the gene silencer REST in neurons destined to die. J. Neurosci. 23, 21122121.
  • Caricasole A., Ferraro T., Rimland J. M. and Terstappen G. C. (2002) Molecular cloning and initial characterization of the MG61/PORC gene, the human homologue of the Drosophila segment polarity gene Porcupine. Gene 288, 147157.
  • Caricasole A., Ferraro T., Iacovelli L., Barletta E., Caruso A., Melchiorri D., Terstappen G. C. and Nicoletti F. (2003) Functional characterization of WNT7A signaling in PC12 cells: interaction with A FZD5 x LRP6 receptor complex and modulation by Dickkopf proteins. J. Biol. Chem. 278, 37 02437 031.
  • Caricasole A., Copani A., Caraci F., Aronica E., Rozemuller A. J., Caruso A., Storto M., Gaviraghi G., Terstappen G. C. and Nicoletti F. (2004) Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J. Neurosci. 24, 60216027.
  • Cedazo-Minguez A. and Cowburn R. F. (2001) Apolipoprotein E: a major piece in the Alzheimer's disease puzzle. J. Cell. Mol. Med. 5, 254266.
  • Cedazo-Minguez A., Popescu B. O., Blanco-Millan J. M., Akterin S., Pei J. J., Winblad B. and Cowburn R. F. (2003) Apolipoprotein E and beta-amyloid (1–42) regulation of glycogen synthase kinase-3beta. J. Neurochem. 87, 11521164.
  • Chiabrando G. A., Sanchez M. C., Skornicka E. L. and Koo P. H. (2002) Low-density lipoprotein receptor-related protein mediates in PC12 cell cultures the inhibition of nerve growth factor-promoted. J. Neurosci. Res. 70, 5764.
  • Corder E. H., Lannfelt L., Bogdanovic N., Fratiglioni L. and Mori H. (1998) The role of APOE polymorphisms in late-onset dementias. Cell. Mol. Life Sci. 54, 928934.
  • D'Arcangelo G., Homayouni R., Keshvara L., Rice D. S., Sheldon M. and Curran T. (1999) Reelin is a ligand for lipoprotein receptors. Neuron 24, 471479.
  • Dale T. C. (1998) Signal transduction by the Wnt family of ligands. Biochem. J. 329, 209223.
  • De Ferrari G. V. and Inestrosa N. C. (2000) Wnt signaling function in Alzheimer's disease. Brain Res. Rev. 33, 112.
  • Eickholt B. J., Walsh F. S. and Doherty P. (2002) An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J. Cell Biol. 157, 211217.
  • Garrido J. L., Godoy J. A., Alvarez A., Bronfman M. and Inestrosa N. C. (2002) Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. FASEB J. 16, 19821984.
  • Hall A. C., Brennan A., Goold R. G., Cleverley K., Lucas F. R., Gordon-Weeks P. R. and Salinas P. C. (2002) Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Mol. Cell. Neurosci. 20, 257270.
  • Han X. (2004) The role of apolipoprotein E in lipid metabolism in the central nervous system. Cell. Mol. Life Sci. 61, 18961906.
  • Herz J. and Beffert U. (2000) Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Nat. Rev. Neurosci. 1, 5158.
  • Herz J. and Bock H. H. (2002) Lipoprotein receptors in the nervous system. Annu. Rev. Biochem. 71, 405434.
  • Hoe H. S., Harris D. C. and Rebeck G. W. (2005) Multiple pathways of apolipoprotein E signaling in primary neurons. J. Neurochem. 93, 145155.
  • Holtzman D. M., Bales K. R., Tenkova T. et al. (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 97, 28922897.
  • Huang Y., Liu X. Q., Wyss-Coray T., Brecht W. J., Sanan D. A. and Mahley R. W. (2001) Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl Acad. Sci. USA 98, 88388843.
  • Huelsken J. and Behrens J. (2002) The Wnt signalling pathway. J. Cell. Sci. 115, 39773978.
  • Iacovelli L., Bruno V., Salvatore L., Melchiorri D., Gradini R., Caricasole A., Barletta E., De Blasi A. and Nicoletti F. (2002) Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways. J. Neurochem. 82, 216223.
  • Inestrosa N., De Ferrari G. V., Garrido J. L., Alvarez A., Olivares G. H., Barria M. I., Bronfman M. and Chacon M. A. (2002) Wnt signaling involvement in beta-amyloid-dependent neurodegeneration. Neurochem. Int. 41, 341344.
  • Irizarry M. C., Cheung B. S., Rebeck G. W., Paul S. M., Bales K. R. and Hyman B. T. (2000) Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP (V717F) transgenic mice. Acta. Neuropathol. 100, 451458.
  • Kim D. H., Inagaki Y., Suzuki T. et al. (1998) A new low density lipoprotein receptor related protein, LRP5, is expressed in hepatocytes and adrenal cortex, and recognizes apolipoprotein E. J. Biochem. 124, 10721076.
  • Koch S., Strasser V., Hauser C., Fasching D., Brandes C., Bajari T. M., Schneider W. J. and Nimpf J. (2002) A secreted soluble form of ApoE receptor 2 acts as a dominant-negative receptor and inhibits Reelin signaling. EMBO J. 21, 59966004.
  • LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S. and Frail D. E. (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid. J. Biol. Chem. 269, 2340323406.
  • Laws S. M., Hone E., Gandy S. and Martins R. N. (2003) Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J. Neurochem. 84, 12151236.
  • Ljungberg M. C., Dayanandan R., Asuni A., Rupniak T. H., Anderton B. H. and Lovestone S. (2002) Truncated apoE forms tangle-like structures in a neuronal cell line. Neuroreport 13, 867870.
  • Ma J., Yee A., Brewer H. B. Jr, Das S. and Potter H. (1994) Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372, 9294.
  • Magoori K., Kang M. J., Ito M. R. et al. (2003) Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E. J. Biol. Chem. 278, 11 33111 336.
  • Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A. and Niehrs C. (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411, 321325.
  • Mao B., Wu W., Davidson G. et al. (2002) Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417, 664667.
  • Miller J. R. (2002) The Wnts. Genome Biol. 3, Reviews 3001.13001.15.
  • Miyata M. and Smith J. D. (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14, 5561.
  • Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W. and Pitas R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850852.
  • Nathan B. P., Chang K. C., Bellosta S., Brisch E., Ge N., Mahley R. W. and Pitas R. E. (1995) The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270, 1979119799.
  • Novak A. and Dedhar S. (1999) Signaling through Beta-catenin and Lef/Tcf. Cell. Mol. Life Sci. 56, 523537.
  • Raber J., Huang Y. and Ashford J. W. (2004) ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol. Aging 25, 641650.
  • Rees S., Coote J., Stables J., Goodson S., Harris S. and Lee M. G. (1996) Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Biotechniques 20, 102110.
  • Schneider W. J. and Nimpf J. (2003) LDL receptor relatives at the crossroad of endocytosis and signaling Cell. Mol. Life Sci. 60, 892903.
  • Stannard A. K., Riddell D. R., Sacre S. M., Tagalakis A. D., Langer C., Von Eckardstein A., Cullen P., Athanasopoulos T., Dickson G. and Owen J. S. (2001) Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J. Biol. Chem. 276, 46 01146 016.
  • Strittmatter W. J. and Bova Hill C. (2002) Molecular biology of apolipoprotein E. Curr. Opin. Lipidol. 13, 119123.
  • Strittmatter W. J. and Roses A. D. (1995) Apolipoprotein E and Alzheimer disease. Proc. Natl Acad. Sci. USA 92, 47254727.
  • Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D. and Roses A. D. (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 80988102.
  • Strittmatter W. J., Saunders A. M., Goedert M., Weisgraber K. H., Dong L. M., Jakes R., Huang D. Y., Pericak-Vance M., Schmechel D. and Roses A. D. (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 11 18311 186.
  • Tamai K., Semenov M., Kato Y., Spokony R., Liu C., Katsuyama Y., Hess F., Saint-Jeannet J. P. and He X. (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407, 530535.
  • Tesseur I., Van Dorpe J., Spittaels K., Van den Haute C., Moechars D. and Van Leuven F. (2000) Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am. J. Pathol. 156, 951964.
  • Tissir F. and Goffinet A. M. (2003) Reelin and brain development. Nat. Rev. Neurosci. 4, 496505.
  • Utton M. A., Vandecandelaere A., Wagner U., Reynolds C. H., Gibb G. M., Miller C. C., Bayley P. M. and Anderton B. H. (1997) Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly. Biochem. J. 323, 741747.
  • Wagner U., Utton M., Gallo J. M. and Miller C. C. (1996) Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J. Cell Sci. 109, 15371543.
  • Willert K. and Nusse R. (1998) Beta-catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev. 8, 95102.
  • Wisniewski T., Castaño E. M., Golabek A., Vogel T. and Frangione B. (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145, 10301035.
  • Wu W., Glinka A., Delius H. and Niehrs C. (2000) Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/beta-catenin signalling. Curr. Biol. 10, 16111614.
  • Zilberberg A., Yaniv A. and Gazit A. (2004) The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway. J. Biol. Chem. 279, 17 53517 542.
  • Zorn A. M. (2001) Wnt signaling: antagonistic Dickkopfs. Curr. Biol. 11, R592R595.